BRIAN BURKHARDT: Open Payments
NPI 1750093555 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 40 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,240
Food & beverage: $1,240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $470 |
| Phathom Pharmaceuticals, Inc. | 9 | $182 |
| Janssen Biotech, Inc. | 5 | $163 |
| GENZYME CORPORATION | 1 | $124 |
| Madrigal Pharmaceuticals | 2 | $123 |
| Ardelyx, Inc. | 2 | $41 |
| QOL Medical, LLC | 1 | $38 |
| PFIZER INC. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
Products named: VOQUEZNA, TREMFYA, LINZESS, DUPIXENT, REZDIFFRA, RINVOQ, SKYRIZI, CREON.
Industry payments across GA — which companies pay providers there.
